On the public citation graph
A prospective, randomized clinical trial of emergency treatment of chemotherapy‐induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony‐stimulating factor (PEG‐rhG‐CSF)
0 signed · 41 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jamainternmed.2020.6319openalex-snapshot
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers
inferredcites →https://doi.org/10.1002/1097-0142(19901101)66:9<1904::aid-cncr2820660908>3.0.co;2-vopenalex-snapshot
Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkin's lymphoma
inferredcites →https://doi.org/10.1002/jbmr.4118openalex-snapshot
Neurogenic Heterotopic Ossifications Develop Independently of Granulocyte Colony-Stimulating Factor and Neutrophils
inferredcites →https://doi.org/10.1007/s00520-006-0201-zopenalex-snapshot
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma
inferredcites →https://doi.org/10.1007/s00520-017-3842-1openalex-snapshot
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations
inferredcites →https://doi.org/10.1007/s10549-017-4609-6openalex-snapshot
Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study
inferredcites →https://doi.org/10.1007/s13304-017-0424-1openalex-snapshot
Breast cancer in young women: an overview
inferredcites →https://doi.org/10.1016/j.addr.2021.114079openalex-snapshot
To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives
inferredcites →https://doi.org/10.1016/j.brainres.2020.146817openalex-snapshot
G-CSF attenuates neuroinflammation and neuronal apoptosis via the mTOR/p70SK6 signaling pathway in neonatal Hypoxia-Ischemia rat model
inferredcites →https://doi.org/10.1016/j.cllc.2015.12.002openalex-snapshot
A Randomized Multicenter Phase III Study of Single Administration of Mecapegfilgrastim (HHPG-19K), a Pegfilgrastim Biosimilar, for Prophylaxis of Chemotherapy-Induced Neutropenia in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
inferredcites →https://doi.org/10.1016/j.critrevonc.2020.102972openalex-snapshot
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence
inferredcites →https://doi.org/10.1016/j.drudis.2014.06.002openalex-snapshot
Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
inferredcites →https://doi.org/10.1093/annonc/mdm438openalex-snapshot
Pegfilgrastim ± ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study
inferredcites →https://doi.org/10.1097/jcp.0000000000000715openalex-snapshot
Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor
inferredcites →https://doi.org/10.1158/1078-0432.ccr-09-0761openalex-snapshot
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
inferredcites →https://doi.org/10.1177/1078155215625459openalex-snapshot
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review
inferredcites →https://doi.org/10.1182/blood.v74.4.1303.1303openalex-snapshot
Evidence for a novel in vivo control mechanism of granulopoiesis: mature cell-related control of a regulatory growth factor
inferredcites →https://doi.org/10.1182/blood.v79.11.2849.2849openalex-snapshot
Pharmacokinetics of subcutaneous recombinant human granulocyte colony- stimulating factor in children
inferredcites →https://doi.org/10.1186/s13045-019-0828-0openalex-snapshot
Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
inferredcites →https://doi.org/10.1186/s13063-020-04749-6openalex-snapshot
The prophylactic and therapeutic effects of moxibustion combined with traditional Chinese medicine decoction for treating chemotherapy-induced myelosuppression in early-stage breast cancer: study protocol for a randomized controlled trial
inferredcites →https://doi.org/10.1200/op.20.01091openalex-snapshot
Is It Safe to Use Long-Acting G-CSF for Febrile Neutropenia Prophylaxis in COVID-19 Pandemic?
inferredcites →https://doi.org/10.1517/13543784.2013.838558openalex-snapshot
New G-CSF agonists for neutropenia therapy
inferredcites →https://doi.org/10.1634/theoncologist.2015-0152openalex-snapshot
A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel
inferredcites →https://doi.org/10.1634/theoncologist.2016-0011openalex-snapshot
A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative…
inferredcites →https://doi.org/10.21147/j.issn.1000-9604.2017.05.04openalex-snapshot
A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia
inferredcites →https://doi.org/10.2147/ott.s157058openalex-snapshot
The role of Hippo signal pathway in breast cancer metastasis
inferredcites →https://doi.org/10.2165/11586040-000000000-00000openalex-snapshot
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
inferredcites →https://doi.org/10.3390/biomedicines9020189openalex-snapshot
Implications of Breast Cancer Chemotherapy-Induced Inflammation on the Gut, Liver, and Central Nervous System
inferredcites →https://doi.org/10.3892/etm.2014.2160openalex-snapshot
Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia
inferredcites →https://doi.org/10.4103/jrms.jrms_463_17openalex-snapshot
Comparison of the effects of pegylated granulocyte-colony stimulating factor and granulocyte-colony stimulating factor on cytopenia induced by dose-dense chemotherapy in breast cancer patients
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4861052openalex-extracted
An Open-Label, Randomized Phase III Study of Telpegfilgrastim in Preventing Chemotherapy-Induced Neutropenia in Patients with Non-Small Cell Lung Cancer
inferred← citeshttps://doi.org/10.1002/cam4.72366openalex-snapshot
Combined Active Bone Marrow‐Sparing Radiotherapy and Prophylactic PEG ‐ rhG ‐ CSF to Reduce Severe Neutropenia During Platinum‐Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
inferred← citeshttps://doi.org/10.1007/s00520-026-10841-5openalex-snapshot
Development and practice of a standardized management pathway for chemotherapy-induced neutropenia in patients with gynecological malignancies
inferred← citeshttps://doi.org/10.1080/14737140.2026.2685304openalex-snapshot
Antibody–drug conjugates: a practical review on clinical management of toxicities
inferred← citeshttps://doi.org/10.1146/annurev-cancerbio-070524-040306openalex-snapshot
Natural and Engineered Cytokines as Cancer Therapeutics
inferred← citeshttps://doi.org/10.1186/s12885-024-13148-yopenalex-snapshot
The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer
inferred← citeshttps://doi.org/10.1186/s12885-024-13156-yopenalex-snapshot
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trial
inferred← citeshttps://doi.org/10.1186/s12885-025-13736-6openalex-snapshot
Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study
inferred← citeshttps://doi.org/10.1200/jco-25-02938openalex-snapshot
WBC Growth Factors: ASCO Guideline Update
inferred← citeshttps://doi.org/10.3389/fonc.2026.1879386openalex-snapshot
Comparative efficacy and safety of etoposide plus PEG-rhG-CSF versus etoposide plus G-CSF for haematopoietic stem cell mobilisation in patients with multiple myeloma and lymphoma
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.